Characterization of a double-CRD-mutated Gal-8 recombinant protein that retains co-stimulatory activity on antigen-specific T-cell response

The Biochemical Journal
Matías Nicolás SchroederOscar Campetella

Abstract

Galectins (Gals) constitute a family of mammalian lectins with affinity for β-galactosides, characterized by the presence of conserved CRDs (carbohydrate-recognition domains). We have found previously that Gal-8, from the tandem-repeat group with two linked CRDs, exerts two separate actions on CD4(+)T-cells: antigen-independent proliferation and, at lower concentration, antigen-specific co-stimulation. Whereas proliferation can be ascribed to the pro-inflammatory role of Gal-8, the co-stimulatory activity of borderline T-cell-specific responses allows the proposal of Gal-8 as an adjuvant in vaccination. To study the relevance of glycan-lectin interaction to these T-cell activities, we generated a double-mutated protein (Gal-8mut) by replacing canonical arginine residues on each CRD, so as to abolish sugar-binding capacity. As expected, Gal-8mut was unable to bind to lactosyl-Sepharose, confirming that lactose recognition was precluded; however, preservation of lectin activity was still evident since Gal-8mut displayed haemoagglutinatory effects and binding capacity to the T-cell surface. To search for glycan affinity, a glycan microarray analysis was conducted which revealed that Gal-8mut lost most low- and intermediate-, but r...Continue Reading

References

Mar 18, 2000·The Journal of Biological Chemistry·N MatsushitaM Hirashima
Sep 12, 2002·Biochimica Et Biophysica Acta·Jun HirabayashiKen-ichi Kasai
Jul 26, 2003·Glycobiology·Nozomu NishiTakanori Nakamura
Feb 6, 2004·Glycoconjugate Journal·Nathalie Bidon-Wagner, Jean-Paul Le Pennec
May 15, 2007·Cellular and Molecular Life Sciences : CMLS·M T ElolaG A Rabinovich
Jul 10, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lora Eshkar SebbanItshak Golan
Sep 26, 2007·Glycobiology·María Virginia TribulattiOscar Campetella
Nov 21, 2007·Journal of Biochemistry·Hitomi YamamotoTakanori Nakamura
Apr 15, 2009·Nature Reviews. Immunology·Gabriel A Rabinovich, Marta A Toscano
Apr 30, 2009·Journal of Leukocyte Biology·María Virginia TribulattiOscar Campetella
Feb 16, 2010·Nature Medicine·Sean R StowellRichard D Cummings
Sep 23, 2010·The Biochemical Journal·Maria Albertina RomaniukMirta Schattner
Nov 26, 2010·The Biochemical Journal·Valentina CattaneoOscar Campetella
Feb 4, 2011·The Journal of Biological Chemistry·Hiroko IdeoKatsuko Yamashita
Feb 24, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·María Virginia TribulattiOscar Campetella
Aug 15, 2013·Cytokine & Growth Factor Reviews·Victor L ThijssenArjan W Griffioen
Dec 7, 2013·Nature Medicine·Steven G ReedChristopher B Fox
Mar 4, 2014·Current Opinion in Microbiology·Huan-Yuan ChenFu-Tong Liu
Jun 25, 2014·Glycobiology·Valentina CattaneoOscar Campetella
Sep 10, 2014·Current Protocols in Bioinformatics·Benjamin Webb, Andrej Sali

❮ Previous
Next ❯

Citations

Oct 2, 2019·Frontiers in Molecular Biosciences·Alyssa M McQuillanRichard D Cummings
Sep 19, 2019·Glycobiology·María V TribulattiOscar Campetella
Jul 4, 2020·IScience·Cecilia Arahí PratoMaría Virginia Tribulatti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.